ArticleDrug, healthcare and patient safety2013

Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.

Jan Thöne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.